CSIMarket Company Name, Ticker, Competitors, else..


Revance Therapeutics Inc   (NASDAQ: RVNC)
Other Ticker:  
 

Revance Therapeutics Inc

RVNC's Fundamental analysis



Looking into Revance Therapeutics Inc growth rates, revenue grew by 5.47 % in the third quarter of 2024 from the same quarter a year ago. Ranking at No. 637

Major Pharmaceutical Preparations industry recorded growth of revenues by 10.2 %

Revance Therapeutics Inc net loss increased from $0 millions, to $-38 millions in third quarter of 2024,

• More on RVNC's Growth


Revance Therapeutics Inc
realized a net loss in trailing twelve months.

Revance Therapeutics Inc realized cash reduction of $ -1.17 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.54.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.17.


• More on RVNC's Valuation
 
 Total Debt (Millions $) 431
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 462,552
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 6.96
 Tangible Book Value (Per Share $) -1.64

Revance Therapeutics Inc
realized net loss in trailing twelve months.

Revance Therapeutics Inc realized cash outflow of $ -1.17per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.54.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.17.


• More on RVNC's Valuation

•  Market Capitalization (Millions $) 380
•  Shares Outstanding (Millions) 104
•  Employees 534
•  Revenues (TTM) (Millions $) 247
•  Net Income (TTM) (Millions $) -2
•  Cash Flow (TTM) (Millions $) -122
•  Capital Exp. (TTM) (Millions $) -4
•  Total Debt (Millions $) 431
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 462,552
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 6.96
•  Tangible Book Value (Per Share $) -1.64

•  Market Capitalization (Millions $) 380
•  Shares Outstanding (Millions) 104
•  Employees 534
•  Revenues (TTM) (Millions $) 247
•  Net Income (TTM) (Millions $) -2
•  Cash Flow (TTM) (Millions $) -122
•  Capital Exp. (TTM) (Millions $) -4





  Ratio
•   Capital Ratio (MRQ) 4.12
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.57
•  Inventory Turnover Ratio (TTM) 1.05





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com